Adamax
Adamax is an advanced synthetic nootropic peptide developed as a highly modified analog of the neuropeptide Semax. The compound is chemically engineered with an N-acetyl group and an adamantane moiety at its C-terminus.
1. Adamax (Research Peptide)
Adamax is a synthetic, experimental nootropic peptide. It is a highly modified analog of the Russian neuro-peptide Semax, engineered to increase structural stability, prevent enzymatic breakdown, and enhance its ability to cross the blood-brain barrier.
Chemical Structure and Mechanism
Adamax builds on the foundational Semax amino acid sequence through two key modifications:
- The addition of an adamantane moiety to the C-terminus.
- The inclusion of an N-acetyl group.
In laboratory models, Adamax is investigated for its ability to upregulate Brain-Derived Neurotrophic Factor (BDNF) and enhance the sensitivity of TrkB receptors in the hippocampus. These pathways are essential for neuroplasticity, memory consolidation, and neuroprotection.
Note: Adamax is an experimental research chemical, typically supplied as a lyophilized powder, and is not FDA-approved for human consumption.